📰 Dexcom News
Page 123 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
May 2, 2023
US Asset Management LLC purchased a new position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 3,544 shares of the medical device company’s stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. […]
May 1, 2023
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) have earned an average rating of “Moderate Buy” from the seventeen ratings firms that are covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target […]
April 30, 2023
DexCom (NASDAQ:DXCM – Get Rating) and Axonics (NASDAQ:AXNX – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings and price targets […]
April 30, 2023
DexCom (NASDAQ:DXCM – Get Rating) released its earnings results on Thursday. The medical device company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02, Briefing.com reports. DexCom had a net margin of 9.68% and a return on equity of 18.65%. The business had revenue of $7.45 billion during the quarter, […]
April 30, 2023
Retirement Systems of Alabama lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 123,743 shares of the medical device company’s stock after selling 6,652 shares during the period. Retirement Systems […]
April 29, 2023
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) hit a new 52-week high on Thursday following a stronger than expected earnings report. The company traded as high as $126.44 and last traded at $121.69, with a volume of 325550 shares. The stock had previously closed at $124.93. The medical device company reported $0.17 earnings per […]
April 29, 2023
TCI Wealth Advisors Inc. lifted its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 36.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 762 shares of the medical device company’s stock after acquiring an additional 204 shares during the period. TCI Wealth Advisors Inc.’s holdings […]
April 29, 2023
DexCom, Inc. (NASDAQ:DXCM – Get Rating) hit a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $126.44 and last traded at $121.69, with a volume of 325550 shares changing hands. The stock had previously closed at $124.93. The medical device company reported $0.17 earnings per […]
April 29, 2023
Westpac Banking Corp lifted its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 64.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 52,231 shares of the medical device company’s stock after purchasing an additional 20,459 shares during the quarter. Westpac Banking Corp’s […]
April 28, 2023
DexCom, Inc. (NASDAQ:DXCM – Get Rating) Director Steven Robert Pacelli sold 5,031 shares of the company’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $126.00, for a total value of $633,906.00. Following the transaction, the director now directly owns 132,686 shares of the company’s stock, valued […]